Market Overview
The global ECG and EKG electrodes market was valued at USD 413 million in 2024 and is projected to reach USD 548 million by 2031, exhibiting a CAGR of 4.2% during the forecast period.
ECG electrodes are medical devices that facilitate the transfer of electrical signals from the skin to monitoring equipment, enabling accurate electrocardiogram readings. These electrodes play a critical role in both diagnostic and continuous monitoring applications across hospitals, clinics, and ambulatory surgical centers. The market growth is primarily driven by the rising global burden of cardiovascular diseases, which according to the World Health Organization account for approximately 17.9 million deaths annually, representing 32% of all global deaths. Additionally, increasing surgical volumes requiring patient monitoring and the growing adoption of telemedicine and remote patient monitoring solutions are contributing to market expansion.
Market size
USD 413 million in 2024
2032 USD 548 million by 2031
of 4.2%
Disposable Electrodes
Reusable Electrodes
Disposable Electrodes dominate the market due to their cost-effectiveness and infection control advantages, while reusable electrodes face challenges in reprocessing consistency across healthcare facilities.
By Application
Hospitals and Clinics
Ambulatory Care Centers
Home Healthcare Settings
Academic Research Facilities
Hospitals
https://www.24lifesciences.com
Our Key Players
3M Company (United States)
Medtronic Plc (Ireland)
Koninklijke Philips N.V. (Netherlands)
Ambu A/S (Denmark)
Conmed Corporation (United States)
Cardinal Health, Inc. (United States)
